Description
Codelac Broncho Pharmacodynamics
Combined product for the treatment of cough, it has mucolytic and expectorant effects, as well as anti-inflammatory activity. The action of Codelac® Broncho is due to the pharmacological properties of its components:
Ambroxol has secretomotor, secretolytic and expectorant action, normalizes the disturbed ratio of serous and mucous components of sputum, increases secretion of surfactant in alveoli. It reduces the viscosity of sputum and promotes its expulsion.
On average, when taken orally, the action of ambroxol starts after 30 minutes, duration of action – 6-12 hours, depending on the dose taken.
Glycyrrates (glycyrrhizic acid and its salts) have anti-inflammatory and antiviral effect. It has a cytoprotective effect due to its antioxidant and membrane stabilizing activity. Potentiates the effect of endogenous glucocorticosteroids, providing anti-inflammatory and anti-allergic effects. Due to the pronounced anti-inflammatory activity, it helps to reduce inflammation in the respiratory tract.
Thermopsis extract has an expectorant effect, having a moderate irritant effect on the mucous membrane receptors of the stomach, reflexively increases the secretion of bronchial glands.
Sodium bicarbonate shifts index of the environment (pH) of bronchial mucus to the alkaline side, reduces sputum viscosity, stimulates motor function of the atrial epithelium and bronchioles.
Indications
Respiratory diseases with sputum retention: acute and chronic bronchitis, pneumonia, chronic obstructive pulmonary disease (COPD), bronchiectatic disease.
Contraindications .
Hypersensitivity to the drug, pregnancy, breast-feeding, children under 12 years of age.
Dosage and administration.
- Inside, with meals.
- Adults and children over 12 years: 1 tablet 3 times a day.
- It is not recommended to use without a doctor’s prescription for more than 4-5 days.
